Several studies have demonstrated that HSF1 is activated and predicts a poor prognosis in various types of cancer, including breast cancer (Santagata et al., 2011), colon cancer (Jacobs and Marnett, 2009), and liver cancer (Li et al., 2014b). Here, HSF1 is linked to cancer.